Education and debate North of England evidence based guideline development project: summary guideline for non-steroidal anti-inflammatory drugs versus basic analgesia in treating the pain of degenerative arthritis
暂无分享,去创建一个
[1] P. Garner,et al. Systematic review of amodiaquine treatment in uncomplicated malaria , 1996, The Lancet.
[2] S. Halstead,et al. The International Clinical Epidemiology Network (INCLEN): a progress report. , 1991, Journal of clinical epidemiology.
[3] Effective Health Care , 1999 .
[4] P. Rochon,et al. A study of manufacturer-supported trials of nonsteroidal anti-inflammatory drugs in the treatment of arthritis. , 1994, Archives of internal medicine.
[5] J Glanville,et al. Finding information on clinical effectiveness , 1998, BMJ.
[6] R. Collins,et al. WHICH ANTICONVULSANT FOR WOMEN WITH ECLAMPSIA - EVIDENCE FROM THE COLLABORATIVE ECLAMPSIA TRIAL , 1995 .
[7] J. Biddulph. Standard Treatment Regimens—A Personal Account of Papua New Guinea Experience , 1989, Tropical doctor.
[8] A. D. de Craen,et al. Analgesic efficacy and safety of paracetamol-codeine combinations versus paracetamol alone: a systematic review , 1996, BMJ.
[9] M. Koch,et al. Prevention of nonsteroidal anti-inflammatory drug-induced gastrointestinal mucosal injury. A meta-analysis of randomized controlled clinical trials. , 1996, Archives of internal medicine.
[10] C. Bulpitt,et al. Joint pain and quality of life; results of a randomised trial. , 1989, British journal of clinical pharmacology.
[11] J. Mason,et al. North of England evidence based guidelines development project: methods of developing guidelines for efficient drug use in primary care , 1998, BMJ.
[12] The Surfaxin-Lavage for Mas Trial Group. Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia Trial , 1995, The Lancet.
[13] A. B. Prasad,et al. British National Formulary , 1994 .
[14] Cindy Farquhar,et al. 3 The Cochrane Library , 1996 .
[15] J. Todd,et al. Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomised controlled trial , 1995, The Lancet.
[16] S. Gore,et al. Impact of rice based oral rehydration solution on stool output and duration of diarrhoea: meta-analysis of 13 clinical trials. , 1992, BMJ.
[17] G. Tildesley,et al. Prevention of gastroduodenal damage induced by non-steroidal anti-inflammatory drugs: controlled trial of ranitidine. , 1988, BMJ.
[18] Andrew D Oxman,et al. Closing the gap between research and practice : an overview of systematic reviews of interventions to promote the implementation of research findings , 2011 .
[19] J. Quick,et al. A strategy for promoting improved pharmaceutical use: the International Network for Rational Use of Drugs. , 1992, Social science & medicine.
[20] G Bréart,et al. From the Cochrane Library , 2000, Revue d'epidemiologie et de sante publique.
[21] Dean T. Jamison,et al. World development report 1993 : investing in health , 1993 .
[22] P. Gøtzsche. Methodology and overt and hidden bias in reports of 196 double-blind trials of nonsteroidal antiinflammatory drugs in rheumatoid arthritis. , 1989, Controlled clinical trials.
[23] M. Uplekar,et al. Private doctors and tuberculosis control in India. , 1993, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[24] R. Martorell,et al. Effectiveness of vitamin A supplementation in the control of young child morbidity and mortality in developing countries. Revised ed. , 1993 .
[25] S. Hill,et al. Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis , 1996, BMJ.
[26] F. Shann,et al. Acute lower respiratory tract infections in children: possible criteria for selection of patients for antibiotic therapy and hospital admission. , 1984, Bulletin of the World Health Organization.
[27] BOMBAY CALCUrIA,et al. World development report 1993--investing in health. , 1993, Communicable disease report. CDR weekly.
[28] K. Brandt,et al. Treatment of knee osteoarthritis: relationship of clinical features of joint inflammation to the response to a nonsteroidal antiinflammatory drug or pure analgesic. , 1992, The Journal of rheumatology.
[29] I. Russell,et al. Comparison of naproxen and acetaminophen in a two-year study of treatment of osteoarthritis of the knee. , 1993, Arthritis and rheumatism.
[30] D. Morley,et al. Growth monitoring , 2001, Lancet.
[31] L. Levine,et al. Nizatidine prevents peptic ulceration in high-risk patients taking nonsteroidal anti-inflammatory drugs. , 1993, Archives of internal medicine.
[32] W. Y. Zhang,et al. Systematic overview of co-proxamol to assess analgesic effects of addition of dextropropoxyphene to paracetamol , 1997, BMJ.
[33] Jeffrey Aronson. WHEN I USE A WORD.. , 1996 .
[34] G. Lindmark,et al. Randomised controlled trial of a reduced-visits programme of antenatal care in Harare, Zimbabwe , 1996, The Lancet.
[35] J. Senior,et al. Misoprostol Reduces Serious Gastrointestinal Complications in Patients with Rheumatoid Arthritis Receiving Nonsteroidal Anti-Inflammatory Drugs , 1995, Annals of Internal Medicine.